Jhunjhunwala-backed Concord Biotech to hit IPO market

Quadria had invested Rs 475.30 crore in 2016 for the 20% stake. Rare Enterprises holds about 24% stake in Concord Biotech.

published on : 17th August 2022

IPOs: Sebi mulls option for pre-filing of offer documents 

In the consultation paper, Sebi has suggested that an issuer should make a public announcement stating that it has done pre-filing of the offer document with Sebi and exchanges.

published on : 12th May 2022

Yatra aims to raise Rs 750 crore via Initial Public Offering

The remaining shares will be sold by Pandara Trust. According to the DRHP, the offer for sale portion of the issue will see 8.3% of the current total outstanding shares be sold.

published on : 29th March 2022

LIC IPO: Government files updated draft papers with Q3 financials 

In the run-up to the mega IPO, on February 13, the government had filed the draft red herring prospectus (DRHP) with the regulator giving details of financial results till September.

published on : 21st March 2022

Glenmark Life Sciences​ files preliminary papers for IPO with SEBI

The board of directors of Glenmark Pharmaceuticals Ltd during its meeting on April 16 approved the offer for sale of up to 73,05,245 equity shares of Rs 2 apiece as part of the IPO.

published on : 17th April 2021